Anti-EDEM1 monoclonal antibody

Pre-made anti-EDEM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EDEM1/EDEM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0737-Ab-1/ GM-Tg-hg-IP0737-Ab-2Anti-Human EDEM1 monoclonal antibodyHuman
GM-Tg-rg-IP0737-Ab-1/ GM-Tg-rg-IP0737-Ab-2Anti-Rat EDEM1 monoclonal antibodyRat
GM-Tg-mg-IP0737-Ab-1/ GM-Tg-mg-IP0737-Ab-2Anti-Mouse EDEM1 monoclonal antibodyMouse
GM-Tg-cynog-IP0737-Ab-1/ GM-Tg-cynog-IP0737-Ab-2Anti-Cynomolgus/ Rhesus macaque EDEM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0737-Ab-1/ GM-Tg-felg-IP0737-Ab-2Anti-Feline EDEM1 monoclonal antibodyFeline
GM-Tg-cang-IP0737-Ab-1/ GM-Tg-cang-IP0737-Ab-2Anti-Canine EDEM1 monoclonal antibodyCanine
GM-Tg-bovg-IP0737-Ab-1/ GM-Tg-bovg-IP0737-Ab-2Anti-Bovine EDEM1 monoclonal antibodyBovine
GM-Tg-equg-IP0737-Ab-1/ GM-Tg-equg-IP0737-Ab-2Anti-Equine EDEM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0737-Ab-1/ GM-Tg-hg-IP0737-Ab-2; GM-Tg-rg-IP0737-Ab-1/ GM-Tg-rg-IP0737-Ab-2;
GM-Tg-mg-IP0737-Ab-1/ GM-Tg-mg-IP0737-Ab-2; GM-Tg-cynog-IP0737-Ab-1/ GM-Tg-cynog-IP0737-Ab-2;
GM-Tg-felg-IP0737-Ab-1/ GM-Tg-felg-IP0737-Ab-2; GM-Tg-cang-IP0737-Ab-1/ GM-Tg-cang-IP0737-Ab-2;
GM-Tg-bovg-IP0737-Ab-1/ GM-Tg-bovg-IP0737-Ab-2; GM-Tg-equg-IP0737-Ab-1/ GM-Tg-equg-IP0737-Ab-2
Products NameAnti-EDEM1 monoclonal antibody
Formatmab
Target NameEDEM1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EDEM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0737-Ag-1Recombinant multi-species EDEM1/ EDEM protein
    ORF Viral VectorpGMLPm002718mouse Edem1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002718mouse Edem1 Lentivirus particle


    Target information

    Target IDGM-IP0737
    Target NameEDEM1
    Gene ID9695,192193,297504,703085,476547,101089086,511008,100059536
    Gene Symbol and SynonymsA130059K23Rik,EDEM,EDEM1,mKIAA0212,RGD1563633
    Uniprot AccessionQ92611
    Uniprot Entry NameEDEM1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000134109
    Target ClassificationN/A

    The target: EDEM1, gene name: EDEM1, also named as EDEM. Enables mannosyl-oligosaccharide 1,2-alpha-mannosidase activity and misfolded protein binding activity. Involved in mannose trimming involved in glycoprotein ERAD pathway; positive regulation of retrograde protein transport, ER to cytosol; and protein targeting to ER. Located in aggresome and endoplasmic reticulum quality control compartment. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.